Completed PHASE1 INTERVENTIONAL 1-arm NCT01925859

EryDex Pharmacokinetics in Healthy Volunteers (EryDex)

Pharmacokinetics Study to Measure Plasma Concentrations of Dexamethasone Following EryDex (Dexamethasone Sodium Phosphate Encapsulated in Autologous Erythrocytes) Infusion in Healthy Volunteers

Sponsor: Quince Therapeutics S.p.A.

Conditions Healthy

Interventions EryDex (dexamethasone sodium phosphate encapsulated erythrocytes)

Updated 7 times since 2017 Last updated: May 29, 2015 Started: Jun 30, 2013 Primary completion: Oct 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy and is currently completed. Quince Therapeutics S.p.A. leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jun 2024 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Jun 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Quince Therapeutics S.p.A.

Data source: Quince Therapeutics S.p.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States